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Abstract
Background: Hepatitis B and C is common in Pakistan and various risk factors are attributable to
its spread.
One thousand and fifty consecutive male cases suffering from chronic liver disease (327 HBV and
723 HCV) were selected from the OPD of public sector hospital and a private clinic dealing
exclusively with the liver patients. To compare the results 723 age and gender matched controls
were selected from the blood transfusion services of the public sector hospital. A standard
questionnaire was filled for all patients and controls which included the information on possible risk
factors.
Findings: Family history of liver disease was significantly higher (43% and 34%) in HBV and HCV
positive cases as compared to 5% in controls [odds ratio 15.6; 95% Confidence Interval CI: 10.1 -
- 24.1, 10.9; 95% Confidence Interval CI: 7.3 -- 16.4] and same trend was seen for death due to liver
disease in the family. Majority 74% hepatitis B positive cases had their shaves done at communal
barbers but this practice was equally prevalent amongst controls (68%), thus negating it as a
possible risk factor, but there is a significant risk with p < 0.05 associated with HCV in male that
get their shave in barber. Very strong association of the disease was found with history of dental
treatment (38% HCV 36% HBV and 21% controls) [Odd ratio 2.3; 95% CI: 1.8-3.0, Odd ratio 2.1;
95% CI: 1.5-2.8], surgery (23% HCV cases,14% HBV cases and 12% controls), history of blood
transfusion was significantly higher in HCV (6%) as compared to controls (2.1%) [Odd ratio 2.9;
95% CI: 1.5-5.5]. History of taking injections for various ailments by the general practitioners (over
90% patients in both hepatitis B and C cases) was significantly higher as compared to 75% in
controls [Odds ratio 3.8, 6.9; 95% CI: 2.4-6.1, 4.5-10.4] but hospitalization was not significant in
HBV and HCV cases.
Conclusion:  Injections, surgery and dental treatment appear as major risk factors for the
transmission of hepatitis B and C in the community. Massive health care awareness drives need to
be done for both health care providers and the public to reduce this menace.
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Background
Hepatitis B and C are the major causes of chronic liver dis-
eases in Pakistan. Using meta analysis of the previous 10
years data, it has been found that the prevalence of HBV
in Pakistan is around 3-4% [1] and HCV is around 5-7%
[2]. Some parts of the country show higher figures for
both these viruses. Both viruses spread though blood and
its products and body secretions. For the prevention of
HBV a potent vaccine is available which has over 95%
protection rates. No vaccine is available for HCV. In Paki-
stan the frequency of HCV appears to be increasing and
the possible sources include frequent injections for minor
ailments, shaving by barbers, dental treatments and blood
transfusions along with surgeries. Improper sterilization
of medical devices and reuse of syringes has been reported
to be the major factor for this high increase in uncon-
trolled studies [3-6]. The present study was done to see if
various risk factors mentioned above show a direct or
indirect association with the HBV or HCV disease and to
compare it with controls.
Methods
One thousand and fifty consecutive male patients suffer-
ing from chronic hepatitis B or C liver disease and coming
for treatment and follow-up to the Gastroenterology and
Hepatology unit of Pakistan Medical Research Centre, Jin-
nah Postgraduate Medical Centre and a private hepatol-
ogy clinic were selected for study. The diagnosis was
confirmed by means of clinical data, deranged liver func-
tion tests and positive hepatic serology i.e. HBsAg or anti
HCV tests. Seven hundred and twenty three age matched
controls (family replacement blood donors) who were
hepatitis B and C negative were selected from the blood
bank of the Jinnah postgraduate medical centre. Informed
consent was taken from patients and controls and ethical
clearance was taken from the institutional review board. A
questionnaire was filled for all cases and controls which
contained the basic information about the individual like
age, gender, past and family history of liver disease. To
determine the possible sources of viral transmission his-
tory of dental treatment which included extraction, filling
or scaling, surgery, blood transfusion, habit of taking
intramuscular injections for minor ailments and shaving
by communal barbers was also taken.
Data management and analysis plan
Statistical Package for Social Sciences (SPSS) version 14.0
was used for data entry and analysis. The analysis was car-
ried out two levels univariate and multivariate analysis.
Mean and standard deviation (SD) were calculated for
quantitative variable (age) and proportions for categorical
variables. Univariate logistic regression analysis was per-
formed to measure association of outcome with each
independent variable. Odds ratios (OR) and 95% confi-
dence intervals (CI) was calculated for each association.
Associations among independent variables were assessed
using appropriate test before performing multivariate
analysis. Multiple logistic regression models were used to
examine the association between the independent varia-
bles and the main outcomes variables, Hepatitis B and C
virus while controlling for the effects of other covariates.
P-value < 0.05 was considered as statistical significant
Results
A total of 1050 patients suffering from chronic HBV or
HCV related liver disease were included in the study. Of
1050 patients 327 were suffering from chronic hepatitis B
(age range15 -- 60 years, mean ± S.D was 31.0 ± 9.4) and
723 from chronic hepatitis C (age range 16-65 years,
mean ± S.D was 32.5 ± 8.4). Seven hundred and twenty
three (723) age matched controls (age range 18-65 years,
mean ± S.D was 32.0 ± 8.6) who were hepatitis B and C
negative were selected from the blood bank of the Jinnah
Postgraduate Medical Centre. Forty three HBV positive
cases and 34% HCV positive cases had family history of
liver diseases which was significantly higher when com-
pared to 5% in controls (P < 0.001). Death in the family
due to liver disease was seen in 5.2% cases having HBV
and 4.3% in HCV, which was not statistically significant
when compared with 3% seen in controls (Table 1, 2).
Of the total males only 18% in each group (HBV/HCV)
had their shave done at home while the rest 74% and 76%
had it done exclusively by barbers or both (home and bar-
bers). There was a significant risk (p < 0.05) of contracting
HCV infection in males that were getting their shave from
communal barbers. History of dental extraction/filling/
scaling was significantly higher (38%) in HCV and (36%)
HBV infected cases (P < 0.001), when compared with con-
trols (21%) Table 1, 2.
Past history of any kind of invasive surgery was present in
23% of HCV and 15% of HBV positive cases when com-
pared with (11%) controls (p < 0.001). History of blood
transfusion was 6% in HCV and 4% in HBV positive cases
and these figures were significantly higher as compared to
2.1% in controls (p < 0.001).
History of therapeutic injection use for various ailments
including intravenous drips was present in over 90%
patients suffering from either hepatitis B or C as compared
to 76% seen in controls, the difference was statistically sig-
nificant (P < 0.001), and in majority of the cases injec-
tions were given by general practitioners by their own
syringe. Only 2% of HCV and 5% of HBV positive cases
said that they took their own syringe for injections (Table
1, 2). History of past hospitalization was present in 15%
cases suffering from HCV and 12% HBV as compared to
14% seen in controls (Table 1, 2).BMC Research Notes 2009, 2:212 http://www.biomedcentral.com/1756-0500/2/212
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Table 1: Risk factors associated with Hepatitis B in Males
Risk factors HBV
(n = 327)
Controls
(n = 723)
Odds Ratio (OR)
95% Confidence Interval (CI)
No % No % P-value
Any family member suffering
from hepatitis B or C
Yes 140 42.8 33 4.6 15.6 (10.1-24.1) 0.001
No 187 57.2 690 95.4
Any family member died
of liver disease
Yes 17 5.2 22 3.0 1.7 (0.8-3.4) 0.124
No 310 94.8 701 97.0
Where do you get your shave No 25 7.6 72 10.0 Reference
Home 59 18.0 159 22.0 1.1 (0.6-1.9) 0.919
Barber 243 74.3 492 68.0 1.4 (1.0-2.3) 0.184
Dental extract/filling/scaling Yes 117 35.8 151 20.9 2.1 (1.5-2.8) 0.001
No 210 64.2 572 79.1
Surgery Yes 47 14.4 82 11.3 1.3 (0.8-1.9) 0.199
No 280 85.6 641 88.7
Blood Transfusion Yes 13 4.0 15 2.1 1.9 (0.8-4.4) 0.118
No 314 96.0 708 97.9
History of IV/IM injection Yes 302 92.4 548 75.8 3.8 (2.4-6.1) 0.001
No 25 7.6 175 24.2
Number of IV/IM injections None 25 7.6 175 24.2 Reference
< 5/year 136 41.6 383 53.0 2.5 (1.5-4.0) 0.001
≥ 5/year 166 50.8 165 22.8 7.0 (4.3-11.6) 0.001
Type of syringe New 16 4.9 178 24.6 8.6 (4.9-15.2) 0.001
Re-used 286 87.5 370 51.2
History of Hospitalization Yes 38 11.6 98 13.6 0.8 (0.5-1.2) 0.444
No 289 88.4 625 86.4
Statistically significant p < 0.05
Table 2: Risk factors associated with Hepatitis C in Males
Risk factors HCV
(n = 723)
Controls
(n = 723)
Odds Ratio (OR)
95% Confidence Interval (CI)
P-value
No % No %
Any family member suffering from hepatitis B or C Yes 249 34.4 33 4.6 10.9 (7.3-16.4) 0.001
No 474 65.6 690 95.4
Any family member died of liver disease Yes 31 4.3 22 3.0 1.4 (0.7-2.5) 0.263
No 692 95.7 701 97.0
Where do you get your shave No 52 7.2 72 10.0 Reference
Home 124 17.2 159 22.0 1.1 (0.6-1.6) 0.807
Barber 547 75.7 492 68.0 1.5 (1.0-2.4) 0.031
Dental extract/filling/scaling Yes 277 38.3 151 20.9 2.3 (1.8-3.0) 0.001
No 446 61.7 572 79.1
Surgery Yes 164 22.7 82 11.3 2.3 (1.7-3.1) 0.001
No 559 77.3 641 88.7
Blood Transfusion. Yes 42 5.8 15 2.1 2.9 (1.5-5.5) 0.001
No 681 94.2 708 97.9
History of IV/IM injection Yes 691 95.6 548 75.8 6.9 (4.5-10.4) 0.001
No 32 4.4 175 24.2
Number IV/IM injection/year None 32 4.4 175 24.2 Reference
<5/year 239 33.1 383 53.0 3.4 (2.2-5.2) 0.001
≥ 5/year 452 62.5 165 22.8 14.9 (9.7-23.2) 0.001
Type of syringe New 17 2.4 178 24.6 19.0 (11.1-33.0) 0.001
Re-used 674 93.2 370 51.2
History of Hospitalization Yes 106 14.7 98 13.6 1.1 (0.8-1.4) 0.596
No 617 85.3 625 86.4BMC Research Notes 2009, 2:212 http://www.biomedcentral.com/1756-0500/2/212
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Multivariate logistic regression analysis showed 4 varia-
bles i.e. family members suffering from liver disease, den-
tal treatments, blood transfusion and number of
therapeutic injections taken by each person per annum, as
significant risk factors for acquiring hepatitis B or c infec-
tion (table 3, 4)
Comments
In the present study a total of 1050 male patients with
chronic HBV or HCV and 723 ages matched controls were
studied. Only male patients were selected for the study
because it is a male dominated society where shaving is a
pure male ordeal. Blood donors were taken as controls
because they represent the same catchments as of patients
and generally are similar in age as patients. Of the patients
327 were suffering from chronic hepatitis "B" and 723
from hepatitis "C" giving a 2 times more occurrence of
HCV than HBV in our population.
In Pakistan HBV exposure in neonates and children occurs
through maternal transmission or as horizontal transmis-
sion from adults [7-9]. The exposure leads to persistence
of infection which later in adulthood is seen either as
healthy carriers or if the virus is active then it shows as
chronic liver disease. Exposure in adults leads to either
acute infection with recovery or no disease if the individ-
ual is immune to the virus [10]. Less than 5% adults
become carriers following acute infection with HBV; so
HBV infection in Pakistan is a problem of neonates and
children. For HCV infection there is no immunity and
once exposed about 60-70% will develop the disease. This
infection is rare in children as the common sources of
infection like shaving, operations, blood transfusions and
injections are less frequent in childhood. In the present
study the HBV to HCV ratio was 2:1 in those who were less
than 35 years of age but this ratio reversed to 1:2 as the age
advanced to 35 years and above. The possible reasons for
high occurrence of HBV in younger age are due to at birth
or neonatal exposure. As the age advances these cases
either seroconvert or suffer and die leading to reduction in
number of positive cases in advancing ages. HCV exposure
usually starts later in life (adolescent life) due to exposure
to above mentioned procedures, therefore we see more
cases of HCV as the age advances. History of chronic liver
disease in the family was seen in 43% HBV cases and this
includes maternal (vertical) and interfamilial (horizontal)
transmission of HBV and is in agreement with the previ-
ous reports of interfamilial transmission [11]. HCV (34%)
infection runs in families in Pakistan and this is probably
due to transmission of the disease from a common source
i.e. barber, general practitioner using un-sterilized
syringes and invasive medical devices.
Shaving by barbers, use of injections for common ail-
ments, blood transfusion, surgery and dental treatments
are thought to be the potential sources of transmission of
HCV in Pakistan. In the present study only 18% cases were
either shaving at home or had beards and were therefore
not shaving, rest of the 75% were shaving at barbers.
These figures were similar when compared with the gen-
eral population (controls) thus negating communal shave
as the source of transmission of the disease.
Intramuscular injections for common ailments and intra-
venous injections as drips for various reasons are used by
majority of the people. Over 90% cases gave history of
taking injections and that also by the syringe of the gen-
eral practitioners and only 5% HBV and 2% HCV cases
took their own syringe. Over 30% cases in both the groups
gave history of taking 5-10 injections per year, while 15%
and 24% of HBV and HCV cases were taking over 20 injec-
tions/year, which was quite high when compared with the
controls (2%). The reuse of disposable syringe is still
being practiced by most health care providers all over
Pakistan.
History of surgery of any kind was twice more common in
HCV positive cases vs. HBV cases and when compared
with the controls this was very high (p = 0.001). Of the
various kinds of surgeries; gall bladder surgery was the
Table 3: Independent risk factors associated with Hepatitis B in males using multivariate logistic regression
New
Risk Factor Adjusted Odds Ratio 95% Confidence Interval P-value
Any family member suffering from hepatitis B & C Yes 14.5 9.5-22.1 0.001
No Reference
Dental extract/filling/scaling Yes 1.9 1.4-2.7 0.001
No Reference
Blood transfusion Yes 2.9 1.2-7.3 0.017
No Reference
History of IV/IM injection/year None Reference
< 5/year 2.1 1.3-3.4 0.003
≥/year 5.8 3.5-9.6 0.001BMC Research Notes 2009, 2:212 http://www.biomedcentral.com/1756-0500/2/212
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commonest. Indigestion is a major presenting feature of
HCV infected cases and often an ultrasound is done to
determine the cause. Once gall stones are found surgery is
done, so more gall bladder surgery in HCV cases might be
related to symptom complex rather than the organ itself.
Apart from surgeries which were done more in HCV cases
the fatigue and weakness seen in HCV cases might have
been a provoking factor for taking a transfusion. Weak-
ness as a good reason to take a transfusion was also shown
in a study done by Khan in 2000 [12].
Though HBV vaccination is available in Pakistan for over
2 decades but still vaccination in adults is lower than
expected. Only 6.7% controls gave history of being vacci-
nated against hepatitis B as against 16% HCV infected
cases. Higher vaccination figures in HCV cases might be
due to advice of the consultant to give prophylaxis before
starting interferon therapy.
Taking preventive therapy as the best option to control
disease spread, it is suggested that more emphasis should
be laid down on HBV vaccination of all infants and chil-
dren. For HCV control public education and awareness
needs to be drastically scaled [13] and public made aware
that equally effective oral medications are available when
required and injections are no better than oral medica-
tions. Shaving by barbers though is not standing out as
the possible risk factor but this practice still needs to be
discouraged and barbers need to be educated on simple
and easy ways for sterilization of instruments. Steriliza-
tion of invasive medical devices like endoscopes (respira-
tory, gut, gynecology, ENT, bones, laparoscopes etc),
surgical instruments, dental instruments etc need to be
done according to the standard SOPs. More potent but yet
ignored sources of transmission include thermometers in
GP clinics, tongue depressors, suction catheters and drain
tubes/bags etc which are used from patient to patient
without changing or cleaning. It is suggested that as a start
the government should make it mandatory that all injec-
tions should available as single dose and multidose injec-
tion vials should be discouraged; moreover each vial
should have a complimentary syringe attached to it. Later
the GP clinics, hospitals and all places where health care
is being provided should be provided with huge quanti-
ties of disposable syringes at a nominal or no cost basis for
at least 3-5 years so that the desire to reuse a syringe can
be overcome. Meanwhile increasing awareness shall
improve the situation in the next few years.
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